Skip to content

Author

G. Thanarajasingam

We have 2 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies.

It is concluded that access to long-term care plans is highly heterogeneous, with insufficient adaptation to the specific needs of haematological malignancy survivors treated curatively or non-curatively, and it is proposed that clinical trials should include extended follow-up, direct patient reporting, and innovative...

T. Wästerlid, B. Valcárcel, Diana Presno et al. · 2 citations
Review Sep 2026

Beyond maximum grade: key regulatory considerations in adverse event reporting.

Key challenges and opportunities related to measuring cumulative and long-term toxicity burden, incorporating patient-reported outcomes, improving adverse event reporting quality and efficiency in clinical trials, and leveraging real-world data, registries, and emerging technologies, such as artificial intelligence and...

Kyriaki Tzogani, T. El-Galaly, N. Everest et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.